Cited by 1,033Antibiotic Resistance in BacteriaAntibiotic Use and ResistanceEnterobacteriaceae and Cronobacter Research

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

Gupta, N., Limbago, B. M., Patel, J. B., Kallen, A. J.·2011·Clinical Infectious Diseases

Open this paper in CoChat — free account

Abstract

Over the past 10 years, dissemination of Klebsiella pneumoniae carbapenemase (KPC) has led to an increase in the prevalence of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Infections caused by CRE have limited treatment options and have been associated with high mortality rates. In the previous year, other carbapenemase subtypes, including New Delhi metallo-β-lactamase, have been identified among Enterobacteriaceae in the United States. Like KPC, these enzymes are frequently found on mobile genetic elements and have the potential to spread widely. As a result, preventing both CRE transmission and CRE infections have become important public health objectives. This review describes the current epidemiology of CRE in the United States and highlights important prevention strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/cid/cir202

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Self-citation
Infectious Diseases Society of America
Enders, J. F. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,296
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,609
Characterization of a New Metallo-β-Lactamase Gene, bla NDM-1 , and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,531
Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
Guideline for Prevention of Catheter-Associated Urinary Tract Infections 2009
Gould, C. V., Umscheid, C. A., Agarwal, R. K., Kuntz, G. M., & Pegues, D. A. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651091 · Cited by 1,406
Management of multidrug-resistant organisms in health care settings, 2006
Siegel, J. D., Rhinehart, E., Jackson, M. M., & Chiarello, L. A. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2007.10.006 · Cited by 1,304
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Patel, G., Huprikar, S. S., Factor, S. H., Jenkins, S. G., & Calfee, D. P. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/592412 · Cited by 837
The New β-Lactamases
Jacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 806

Flagged first, then by citations

Show all 48 references

Research works printed but not linked: 1

2009, MMWR. Morbidity and mortality weekly report, 58, 256

Sorted by citations

Items 401–500 of 1,000

Pharmacokinetics of the Meropenem Component of Meropenem‐Vaborbactam in the Treatment of KPC ‐Producing Klebsiella pneumoniae Bloodstream Infection in a Pediatric Patient
Hanretty, A. M., Kaur, I., Evangelista, A. T., Moore, W. S., Enache, A., Chopra, A., & Cies, J. J. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2187 · Cited by 27
Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli
Aunins, T. R., Erickson, K. E., & Chatterjee, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922187117 · Cited by 27
Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy
Rossi, M., Chatenoud, L., Gona, F., Sala, I., Nattino, G., D'Antonio, A., Castelli, D., Itri, T., Morelli, P., Bigoni, S., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2705.203662 · Cited by 27
Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring blaNDM-1 and blaNDM-5
Terbtothakun, P., Nwabor, O. F., Siriyong, T., Voravuthikunchai, S. P., & Chusri, S. (2021) · Antibiotics · doi:10.3390/antibiotics10081023 · Cited by 27
In Vitro and In Vivo Activities of OP0595, a New Diazabicyclooctane, against CTX-M-15-Positive Escherichia coli and KPC-Positive Klebsiella pneumoniae
Morinaka, A., Tsutsumi, Y., Yamada, K., Takayama, Y., Sakakibara, S., Takata, T., Abé, T., Furuuchi, T., Inamura, S., Sakamaki, Y., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02704-15 · Cited by 27
Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria
Otsuka, Y. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00842 · Cited by 27
Genome sequencing and comparative analysis of an NDM-1-producingKlebsiella pneumoniaeST15 isolated from a refugee patient
Salloum, T., Arabaghian, H., Alousi, S., Abboud, E., & Tokajian, S. T. (2017) · Pathogens and Global Health · doi:10.1080/20477724.2017.1314069 · Cited by 26
Resistance to Colistin in Klebsiella pneumoniae: A 4.0 Strain?
Granata, G., & Petrosillo, N. (2017) · Infectious Disease Reports · doi:10.4081/idr.2017.7104 · Cited by 26
Risk Factors for the First Episode of Klebsiella pneumoniae Resistant to Carbapenems Infection in Critically Ill Patients: A Prospective Study
Mantzarlis, K. D., Makris, D. A., Manoulakas, E., Karvouniaris, M., & Zakynthinos, E. G. (2013) · BioMed Research International · doi:10.1155/2013/850547 · Cited by 26
Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae
Piano, S. S., Romano, A., Rosi, S., Gatta, A., & Angeli, P. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328355d8a2 · Cited by 26
The Time Spent Cleaning a Hospital Room Does Not Correlate with the Thoroughness of Cleaning
Rupp, M. E., Adler, A., Schellen, M., Cassling, K., Fitzgerald, T. A., Sholtz, L., Lyden, E. R., & Carling, P. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/668779 · Cited by 26
Molecular characterization of Klebsiella pneumoniae carbapenemase-producing isolates in southern Brazil
Ribeiro, V. B., Andrade, L. N., Linhares, A. R., Barin, J., Darini, A. L. D. C., Zavascki, A. P., & Barth, A. L. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.062141-0 · Cited by 26
Antimicrobial Resistance Surveillance and New Drug Development
Sader, H. S., Rhomberg, P. R., Fuhrmeister, A. S., Mendes, R. E., Flamm, R. K., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy345 · Cited by 25
Transmission and molecular characteristics of blaNDM-producing Escherichia coli between companion animals and their healthcare providers in Guangzhou, China
Wang, M.-G., Fang, C., Liu, K., Wang, L., Sun, R.-Y., Zhang, R., Fang, L., Sun, J. G., Liu, Y.-H., & Liao, X. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab382 · Cited by 25
Application of Nucleotide-Based Kinetic Modeling Approaches to Predict Antibiotic Resistance Gene Degradation during UV- and Chlorine-Based Wastewater Disinfection Processes: From Bench- to Full-Scale
He, H., Choi, Y., Wu, S. J., Fang, X., Anderson, A., Liou, S.-Y., Roberts, M. C., Lee, Y., & Dodd, M. C. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.2c00567 · Cited by 27
Establishment of a Statewide Network for Carbapenem-Resistant Enterobacteriaceae Prevention in a Low-Incidence Region
Pfeiffer, C. D., Cunningham, M. C., Poissant, T. M., Furuno, J. P., Townes, J. M., Leitz, A., Thomas, A. R., Buser, G. L., Arao, R. F., & Beldavs, Z. G. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/675605 · Cited by 25
The prevalence of antibiotic resistance of Enterobacteriaceae strains isolated in community- and hospital-acquired infections in teaching hospitals of Hamadan, west of Iran.
Hashemi, S. H., Esna‐Ashari, F., Tavakoli, S., & Mamani, M. (2013) · PubMed · Cited by 25
Antibiotic Resistance
Rai, M., Kon, K. V., Gade, A., Ingle, A. P., Nagaonkar, D., Paralikar, P., & da Silva, S. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803642-6.00006-x · Cited by 29
Predicting Carbapenem-Resistant Enterobacteriaceae Carriage at the Time of Admission Using a State-Wide Hospital Discharge Database
Lin, M. Y., Ray, M. J., Rezny, S., Runningdeer, E., Weinstein, R. A., & Trick, W. E. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz483 · Cited by 25
Antibiotic Resistance, Part 2: Gram-negative Pathogens
Oliphant, C. M., & Eroschenko, K. (2014) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2014.10.008 · Cited by 25
Newer β-Lactam/β-Lactamase Inhibitor for Multidrug-Resistant Gram-Negative Infections: Challenges, Implications and Surveillance Strategy for India
Veeraraghavan, B., Pragasam, A. K., Bakthavatchalam, Y. D., Anandan, S., Ramasubramanian, V., Swaminathan, S., Gopalakrishnan, R., Soman, R. N., Abraham, O., Ohri, V. C., et al. (2018) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_18_326 · Cited by 24
Fecal Carriage and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae from Inpatient Children in a Pediatric Hospital of Shanghai
Xu, Q., Pan, F., Sun, Y., Wang, C., Shi, Y., Zhang, T., Yu, F., & Zhang, H. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s275549 · Cited by 22
Evaluation of regional antibiograms to monitor antimicrobial resistance in hampton roads, Virginia
Var, S. K., Hadi, R., & Khardori, N. M. (2015) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-015-0080-6 · Cited by 24
Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings?
Apisarnthanarak, A., Hsu, L. Y., Khawcharoenporn, T., & Mundy, L. M. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.164 · Cited by 24
Recent advances in the rational design and optimization of antibacterial agents
Jones, J. A., Virga, K. G., Gumina, G., & Hevener, K. E. (2016) · MedChemComm · doi:10.1039/c6md00232c · Cited by 24
A Carbon‐Dot‐Based Fluorescent Nanosensor for Simple Visualization of Bacterial Nucleic Acids
Lee, H. N., Ryu, J. S., Shin, C., & Chung, H. J. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201700086 · Cited by 24
Prevalence of fosfomycin resistance and plasmid-mediated fosfomycin-modifying enzymes among carbapenem-resistant Enterobacteriaceae in Zhejiang, China
Huang, L., Hu, Y., & Zhang, R. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000578 · Cited by 24
Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital
Helal, R. B., Dziri, R., Chedly, M., Klibi, N., Barguellil, F., Asli, M. S. E., & Moussa, M. B. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0013 · Cited by 24
Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
Blaskovich, M. A. T., Pitt, M. E., Elliott, A. G., & Cooper, M. A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1483240 · Cited by 24
Infection prevention and control practices related to carbapenemase-producing Enterobacteriaceae (CPE) in acute-care hospitals in Ontario, Canada
Jamal, A. J., Jeldes, F. G., Baqi, M., Borgia, S. M., Johnstone, J., Katz, K. C., Kohler, P. P., Muller, M. P., McGeer, A., & for the CPE Investigators of the Toronto Invasive Bacterial Diseases Network (2019) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2019.173 · Cited by 24
Septic Shock Caused by Klebsiella pneumoniae Carbapenemase-Producing Enterobacter gergoviae in a Neutropenic Patient with Leukemia
Satlin, M. J., Jenkins, S. G., Chen, L., HELFGOTT, D. C., Feldman, E. J., Kreiswirth, B. N., & Schuetz, A. N. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00004-13 · Cited by 24
A decade of change in susceptibility patterns of Gram-negative blood culture isolates: a single center study
Alagesan, M., Gopalakrishnan, R., Panchatcharam, S. N., Sureshkumar, D., Ananth, T. M., & Ramasubramanian, V. (2015) · GERMS · doi:10.11599/germs.2015.1073 · Cited by 24
Epidemiology of Extended-Spectrum ^|^beta;-Lactamase, AmpC, and Carbapenemase Production in Proteus mirabilis
Datta, P., Gupta, V., Arora, S. K., Garg, S., & Chander, J. (2014) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.67.44 · Cited by 23
Determination of MIC Distribution of Arbekacin, Cefminox, Fosfomycin, Biapenem and Other Antibiotics against Gram-Negative Clinical Isolates in South India: A Prospective Study
Rajenderan, S., Veeraraghavan, B., Anandan, S., Sahni, R. D., Tansarli, G. S., & Falagas, M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103253 · Cited by 23
Differentiating Epidemic from Endemic or Sporadic Infectious Disease Occurrence
Riley, L. W. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.ame-0007-2019 · Cited by 23
Trends in Incidence of Carbapenem-Resistant Enterobacterales in 7 US Sites, 2016─2020
Duffy, N., Li, R., Czaja, C. A., Johnston, H. L., Janelle, S. J., Jacob, J. T., Smith, G., Wilson, L. E., Vaeth, E., Lynfield, R., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad609 · Cited by 23
Practical Lessons on Antimicrobial Therapy for Critically Ill Patients
Cusack, R. A. F., Little, E., & Martín‐Loeches, I. (2024) · Antibiotics · doi:10.3390/antibiotics13020162 · Cited by 23
Antibiotic susceptibility pattern of Enterobacteriaceae and non-fermenter Gram-negative clinical isolates of microbial resource orchid
Satyaseela, M. P., Periasamy, H., Bharani, T., Franklyne, J. S., Biswas, P., & Solanki, S. (2015) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.149121 · Cited by 23
Evaluation of the Oxoid Brilliance™ CRE Agar for the detection of carbapenemase-producing Enterobacteriaceae
Stuart, J. W. T. C., Voets, G. M., Rottier, W. C., Voskuil, S., Scharringa, J., van Dijk, K., Fluit, A. C., & Hall, M. L.-V. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1896-7 · Cited by 23
Nested Case-Control Study of the Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae
Nigo, M., Cevallos, C. S., Woods, K. L., Flores, V. M., Francis, G., Perlman, D. C., Revuelta, M., Mildvan, D., Waldron, M., Gomez, T., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00827-13 · Cited by 23
Novel antimicrobial-resistant bacteria among patients requiring chronic hemodialysis
Snyder, G. M., & D’Agata, E. M. C. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328350089b · Cited by 23
NDM-1 and rmtC-Producing Klebsiella pneumoniae Isolates in Turkey
Gökmen, T., Nağıyev, T., Meral, M., Önlen, C., Heydari, F. E., & Köksal, F. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.33990 · Cited by 23
Carbapenem-Resistant Klebsiella pneumoniae Infection in Three New York City Hospitals Trended Downwards From 2006 to 2014
Park, S. O., Liu, J., Furuya, E. Y., & Larson, E. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw222 · Cited by 23
Carbapenemase-producing Enterobacterales in hospital drains in Southern Ontario, Canada
Jamal, A. J., Mataseje, L. F., Brown, K. A., Katz, K. C., Johnstone, J., Muller, M. P., Allen, V. G., Borgia, S. M., Boyd, D. A., Ciccotelli, W. A., et al. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.09.007 · Cited by 23
NanoKeepers: stimuli responsive nanocapsules for programmed specific targeting and drug delivery
Hernández, F. J., Hernandez, L. I., Kavruk, M., Arıca, Y., Bayramoğlu, G., Borsa, B. A., Öktem, H. A., Schäfer, T., & Özalp, V. C. (2014) · Chemical Communications · doi:10.1039/c4cc04248d · Cited by 22
Carbapenemase-producing Enterobacteriaceae – once positive always positive?
Vink, J., Otter, J. A., & Edgeworth, J. D. (2019) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000596 · Cited by 22
Carbapenem-resistant Enterobacteriaceae (CRE) and gram-negative bacterial infections in south-west Nigeria: a retrospective epidemiological surveillance study
Adesanya, O. A., & Igwe, H. A. (2020) · AIMS Public Health · doi:10.3934/publichealth.2020062 · Cited by 22
Risk Factors for the Acquisition of a blaNDM-5 Carbapenem-Resistant Escherichia coli in a Veterinary Hospital
Lavigne, S. H., Cole, S. D., Daidone, C., & Rankin, S. C. (2021) · Journal of the American Animal Hospital Association · doi:10.5326/jaaha-ms-7105 · Cited by 22
Disparity in infection control practices for multidrug-resistant Enterobacteriaceae
Lowe, C. F., Katz, K. C., McGeer, A., & Muller, M. P. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2011.11.008 · Cited by 22
Tracking Colistin-Treated Patients to Monitor the Incidence and Outcome of Carbapenem-Resistant Gram-Negative Infections
Kadri, S. S., Hohmann, S. F., Orav, E. J., Bonne, S. L., Moffa, M. A., Timpone, J. G., Strich, J. R., Palmore, T. N., Christopher, K. B., Varughese, C. A., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu741 · Cited by 22
Evaluation of polymyxin susceptibility profile among KPC ‐producing Klebsiella pneumoniae using Etest and MicroScan WalkAway automated system
Perez, L. R. R. (2015) · Apmis · doi:10.1111/apm.12438 · Cited by 22
Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006–2010
Ho, C., Ho, M., Liu, Y.-C., Toh, H. S., Lee, Y.-L., Liu, Y.-M., Huang, C.-C., Lu, P., Liu, C.-E., Chen, Y., et al. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(12)70006-7 · Cited by 22
Study on MICs of Tigecycline in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae (CRE) at a Tertiary Care Centre in North India
Khare, V. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/24594.9629 · Cited by 22
Regional Spread of an Outbreak of Carbapenem-Resistant Enterobacteriaceae Through an Ego Network of Healthcare Facilities
Ray, M. J., Lin, M. Y., Tang, A. S., Arwady, M. A., Lavin, M. A., Runningdeer, E., Jovanov, D., & Trick, W. E. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy084 · Cited by 22
In vitro Activity of Doripenem plus Fosfomycin against Drug-Resistant Clinical Blood Isolates
Lingscheid, T., Tobudic, S., Poeppl, W., Mitteregger, D., & Burgmann, H. (2013) · Pharmacology · doi:10.1159/000348572 · Cited by 22
Molecular Mechanisms of Antibiotic Resistance in Bacteria
Opal, S. M., & Pop-Vicas, A. E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00018-7 · Cited by 26
Antibacterial activity of Staphylococcus aureus biofilm under combined exposure of glutaraldehyde, near-infrared light, and 405-nm laser
Tran, V. N., Dasagrandhi, C., Truong, V. G., Kim, Y., & Kang, H. W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202821 · Cited by 22
Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea
Park, J. W., Lee, H., Park, S. Y., & Kim, T. H. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0497-3 · Cited by 21
Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing Enterobacterales in Animal Infection Models: a Current State of Affairs
Asempa, T. E., Abdelraouf, K., & Nicolau, D. P. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02271-20 · Cited by 21
Tabtoxinine-β-lactam is a “stealth” β-lactam antibiotic that evades β-lactamase-mediated antibiotic resistance
Hart, K. M., Reck, M. R., Bowman, G. R., & Wencewicz, T. A. (2015) · MedChemComm · doi:10.1039/c5md00325c · Cited by 21
Bugs, hosts and ICU environment: Countering pan-resistance in nosocomial microbiota and treating bacterial infections in the critical care setting
Maseda, E., Mensa, J., Valía, J.-C., Gomez-Herreras, J. I., Ramasco, F., Samsó, E., Chiveli, M.-A., Pereira, J., González, R., Aguilar, G., et al. (2014) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2013.11.012 · Cited by 21
In Vitro Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae
Huang, D. S., Yu, B. J., Diep, J. K., Sharma, R., Dudley, M. N., Monteiro, J., Kaye, K. S., Pogue, J. M., Abboud, C. S., & Rao, G. G. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00073-17 · Cited by 21
Emergence of an Escherichia coli strain co-harbouring mcr-1 and blaNDM-9 from a urinary tract infection in Taiwan
Lin, Y.-C., Kuroda, M., Suzuki, S., & Mu, J. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.10.003 · Cited by 21
Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007)
Kuti, J. L., Kim, A., Cloutier, D. J., & Nicolau, D. P. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-0251-4 · Cited by 21
Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study
Wu, X., Zhu, Y., Chen, Q., Gong, L., Lin, J. W., Lv, D., & Feng, J. (2016) · BioMed Research International · doi:10.1155/2016/8395268 · Cited by 21
1,4,7-Triazacyclononane Restores the Activity of β-Lactam Antibiotics against Metallo-β-Lactamase-Producing Enterobacteriaceae : Exploration of Potential Metallo-β-Lactamase Inhibitors
Somboro, A. M., Amoako, D. G., Sekyere, J. O., Kumalo, H. M., Khan, R. B., Bester, L. A., & Essack, S. Y. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02077-18 · Cited by 20
Analysis of carbapenemases genes of carbapenem-resistant Klebsiella pneumoniae isolated from Tehran heart center
Pourgholi, L., Farhadinia, H., Hosseindokht, M., Ziaee, S., Nosrati, R., Nosrati, M., & Boroumand, M. (2022) · Iranian Journal of Microbiology · doi:10.18502/ijm.v14i1.8799 · Cited by 20
Active Surveillance for Carbapenem-Resistant Enterobacterales (CRE) Colonization and Clinical Course of CRE Colonization among Hospitalized Patients at a University Hospital in Thailand
Wangchinda, W., Thamlikitkul, V., Watcharasuwanseree, S., & Tangkoskul, T. (2022) · Antibiotics · doi:10.3390/antibiotics11101401 · Cited by 20
Clinical and Genomic Characterization of Carbapenem-Resistant Klebsiella pneumoniae with Concurrent Production of NDM and OXA-48-like Carbapenemases in Southern California, 2016–2022
Cerón, S., Salem-Bango, Z., Contreras, D. A., Ranson, E. L., & Yang, S. (2023) · Microorganisms · doi:10.3390/microorganisms11071717 · Cited by 20
Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias
Wan, Q., Ye, Q. F., & Yuan, H. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2271-z · Cited by 20
Primer caso de detección de blaKpc en Chile: desde Italia a un hospital público de Santiago
Cifuentes, M., García, P., Martín, P. S., Silva, F., Zúñiga, J., Reyes, S., Rojas, R., Ponce, R., Quintanilla, R. A., Delpiano, L., et al. (2012) · Revista chilena de infectología · doi:10.4067/s0716-10182012000200018 · Cited by 20
Comparison of clinical methods for detecting carbapenem-resistant Enterobacteriaceae
Kost, K., Yi, J., Rogers, B. B., & Jerris, R. R. (2017) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2017.03.002 · Cited by 20
Ceftazidime–Avibactam Antimicrobial Activity and Spectrum When Tested Against Gram-negative Organisms From Pediatric Patients
Sader, H. S., Huband, M. D., Duncan, L. R., & Flamm, R. K. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001859 · Cited by 20
VIM-Klebsiella oxytoca outbreak in a Neonatal Intensive Care Unit. This time it wasn't the drain
Herruzo, R., Carrascoso, G. R., Gallego, S., Diez, J., Sarriá, A., & Omeñaca, F. (2016) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2017.58.4.692 · Cited by 20
Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship
Alemkere, G., Tenna, A., & Engidawork, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212661 · Cited by 20
Phenol‐Soluble‐Modulin‐Inspired Amphipathic Peptides Have Bactericidal Activity against Multidrug‐Resistant Bacteria
Zeng, P., Xu, C., Cheng, Q., Liu, J., Gao, W., Yang, X., Wong, K., Chen, S., & Chan, K. (2019) · ChemMedChem · doi:10.1002/cmdc.201900364 · Cited by 20
Clinical characteristics, risk factors, and outcomes of patients hospitalized in the US military health system with carbapenem-resistant Enterobacteriaceae infection
Adams, D. J., Susi, A., & Nylund, C. M. (2019) · American Journal of Infection Control · doi:10.1016/j.ajic.2019.10.006 · Cited by 20
Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study
Fang, L., Xu, H., Ren, X., Li, X., Ma, X., Zhou, H., Hong, G., & Liang, X. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00462 · Cited by 20
Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens
Annamanedi, M., Varma, G. Y. N., Anuradha, K. T., & Kalle, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00805 · Cited by 20
Trends in Antimicrobial Resistance against Enterobacteriaceae Strains Isolated from Blood
Liu, X., Lyu, Y., Li, Y., Xue, F., & Liu, J. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.213407 · Cited by 20
Recommendations for the control of carbapenemase-producing Enterobacteriaceae (CPE): A guide for acute care health facilities
Richards, M., Cruickshank, M., Cheng, A., Gandossi, S., Quoyle, C., Stuart, R. L., Sutton, B. A., Turnidge, J. D., Bennett, N. J., Buising, K. L., et al. (2017) · Infection Disease & Health · doi:10.1016/j.idh.2017.09.001 · Cited by 20
Antibacterial and antibiofilm efficacy of eugenol, carvacrol, and cinnamaldehyde against colistin-resistant Klebsiella pneumoniae
Kashi, M., Farahani, A. S., Ahmadi, A., Shariati, A., & Akbari, M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10564-6 · Cited by 19
Dissemination mechanisms of NDM genes in hospitalized patients
Zhai, Y., Lee, S.-Y., Teng, L., Ma, Z., Hilliard, N. B., May, R. J., Brown, S. A., Yu, F., DeSear, K., Cherabuddi, K., et al. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab032 · Cited by 19
Elevated Incidences of Antimicrobial Resistance and Multidrug Resistance in the Maumee River (Ohio, USA), a Major Tributary of Lake Erie
Mukherjee, M., Marie, L., Liles, C., Mustafa, N., Bullerjahn, G. S., Gentry, T. J., & Brooks, J. P. (2021) · Microorganisms · doi:10.3390/microorganisms9050911 · Cited by 19
Multidrug-resistant Enterobacterales infections in abdominal solid organ transplantation
Pilmis, B., Weiss, E., Scemla, A., Monnier, A. L., Grossi, P., Slavin, M. A., van Delden, C., Lortholary, O., Paugam‐Burtz, C., & Zahar, J. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.06.005 · Cited by 19
Newly Detected Transmission of blaKPC-2 by Outer Membrane Vesicles in Klebsiella Pneumoniae
Chen, L.-J., Jing, X., Meng, D., Wu, T., Zhou, H., Sun, R., Min, X., Liu, R., & Zeng, J. (2023) · Current Medical Science · doi:10.1007/s11596-022-2680-7 · Cited by 19
Activity of tigecycline and comparators against skin and skin structure pathogens: global results of the Tigecycline Evaluation and Surveillance Trial, 2004–2009
Namdari, H., Tan, T. Y., & Dowzicky, M. J. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.09.021 · Cited by 19
Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains
Hao, M., Schuyler, J. A., Zhang, H., Shashkina, E., Du, H., Fouts, D. E., Satlin, M. J., Kreiswirth, B. N., & Chen, L. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab131 · Cited by 18
Passive immunotherapy using chicken egg yolk antibody (IgY) against diarrheagenic E. coli: A systematic review and meta-analysis
Karthikeyan, M., Indhuprakash, S. T., Gopal, G., Ambi, S. V., Krishnan, U. M., & Diraviyam, T. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108381 · Cited by 18
Estimating the economic cost of carbapenem resistant Enterobacterales healthcare associated infections in Singapore acute-care hospitals
Cai, Y., Hoo, G. S. R., Lee, W., Tan, B. H., Yoong, J., Teo, Y., Graves, N., Lye, D. C., & Kwa, A. L. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001311 · Cited by 18
Molecular and Clinical Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Isolates at a Tertiary Hospital in Wuhan, China
Hu, F., Lin, M.-L., Mou, J.-L., Feng, J.-H., Huang, K., Lao, Y.-J., Cheng, J., & Lin, J. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s397975 · Cited by 18
Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections
Eckmann, C., & Solomkin, J. S. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.994504 · Cited by 18
Promoter deletions of Klebsiella pneumoniae carbapenemase (KPC)-encoding genes ( bla KPC -2 ) and efflux pump (AcrAB) on β-lactam susceptibility in KPC-producing Enterobacteriaceae
Seecoomar, G. D., Marmol, B., & Kwon, D. H. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12273 · Cited by 18
Standard Versus Prolonged Doripenem Infusion for Treatment of Gram-Negative Infections
Hsaiky, L. M., Murray, K. P., Kokoska, L., Desai, N. G., & Cha, R. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1s032 · Cited by 18
Fecal microbiota transplantation: Is there a role in the eradication of carbapenem-resistant Klebsiella pneumoniae intestinal carriage?
Ponte, A., Pinho, R. T., & Mota, M. (2017) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2017.4425/2016 · Cited by 18
Clinical outcomes of carbapenem de-escalation regardless of microbiological results: A propensity score analysis
Sadyrbaeva-Dolgova, S., Aznarte-Padial, P., Pasquau-Liaño, J., Ruíz, M. E., Hernández, M. Á. C., & Hidalgo-Tenorio, C. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.04.034 · Cited by 18
4-Amino-2-Sulfanylbenzoic Acid as a Potent Subclass B3 Metallo-β-Lactamase-Specific Inhibitor Applicable for Distinguishing Metallo-β-Lactamase Subclasses
Wachino, J., Kanechi, R., Nishino, E., Mochizuki, M., Jin, W., Kimura, K., Kurosaki, H., & Arakawa, Y. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01197-19 · Cited by 18
Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program
Faraone, A., Poggi, A., Cappugi, C., Tofani, L., Riccobono, E., Giani, T., & Fortini, A. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.03.017 · Cited by 19
Carbapenem-resistant Escherichia coli from shrimp and salmon available for purchase by consumers in Canada: a risk profile using the Codex framework
Loest, D., Uhland, F., Young, K. M., Li, X.-Z., Mulvey, M., Reid-Smith, R., Sherk, L. M., & Carson, C. (2022) · Epidemiology and Infection · doi:10.1017/s0950268822001030 · Cited by 17
Optimal Treatment for Complicated Intra-abdominal Infections in the Era of Antibiotic Resistance: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Combined Therapy With Metronidazole
Mikamo, H., Yuasa, A., Wada, K., Crawford, B., & Sugimoto, N. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw143 · Cited by 18

Authors: Gupta, N., Limbago, B. M., Patel, J. B., & Kallen, A. J.
Affiliations: Centers for Disease Control and Prevention (US)
ORCID: Gupta, N.
Patel, J. B.
Kallen, A. J.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2011-06-07
Volume: 53
Issue: 1
Pages: 60-67
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1093/cid/cir202
OpenAlex: W2113898837
Cited by: 1,033
References: 48
Citations by year: 2026: 20 · 2025: 32 · 2024: 36 · 2023: 54 · 2022: 60 · 2021: 68 · 2020: 78 · 2019: 96 · 2018: 80 · 2017: 99 · 2016: 82 · 2015: 92 · 2014: 97 · 2013: 77 · 2012: 54
FWCI: 4.10
Type: journal article
Language: en
Open access: closed
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Funders: Kimberly-Clark
Centers for Disease Control and Prevention
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Life Sciences › Immunology and Microbiology › Microbiology › Enterobacteriaceae and Cronobacter Research
Keywords: carbapenem-resistant Enterobacteriaceae, KPC, New Delhi metallo-beta-lactamase, mobile genetic elements, infection control, antimicrobial resistance, United States
MeSH terms: Bacterial Proteins, beta-Lactamases, Enterobacteriaceae, Enterobacteriaceae Infections, Humans, Carbapenems, Drug Resistance, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks